Holen Sie sich die Stockscreener-App
467.55
0.21%
-0.895
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$468.44
Offen:
$468.64
24-Stunden-Volumen:
455.98K
Relative Volume:
0.26
Marktkapitalisierung:
$167.55B
Einnahmen:
$9.15B
Nettoeinkommen (Verlust:
$2.63B
KGV:
65.21
EPS:
7.17
Netto-Cashflow:
$1.99B
1W Leistung:
-2.45%
1M Leistung:
-5.73%
6M Leistung:
-19.53%
1J Leistung:
-2.45%
1-Tages-Spanne:
$464.80
$468.64
1-Wochen-Bereich:
$461.25
$483.63
52-Wochen-Spanne:
$425.00
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
467.39 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.97 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
81.03 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
285.26 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
245.09 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-23 | Herabstufung | Erste Group | Buy → Hold |
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Evercore ISI Lowered the Firm’s PT on Intuitive Surgical (ISRG), Kept an In Line Rating - MSN
Intuitive Surgical GM Iman Jeddi to share at RoboBusiness how the company keeps innovating - The Robot Report
Stock Analysis | Intuitive Surgical OutlookMixed Signals Cloud Short-Term Prospects Amid Strong Fundamentals - AInvest
Jim Cramer on Intuitive Surgical: “I Like That Company So Much” - MSN
Intuitive Surgical's Stock Slides as 93rd-Busiest Trade Amid Asia Expansion Hurdles - AInvest
ISRG's International Push for Ion: Strategic Bet or Overstretch? - The Globe and Mail
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know - Yahoo Finance
CMR Surgical hires Chris O’Hara to drive US robot expansion - Yahoo Finance
Intuitive Surgical's Robotic Surge: Can Long-Term Growth Offset Near-Term Pressures? - AInvest
Neurosurgery Surgical Robots Market Generated Opportunities, - openPR.com
If You're in Your 30s, Consider Buying These 2 Healthcare Stocks - AOL.com
If You're in Your 30s, Consider Buying These 2 Healthcare Stocks - The Motley Fool
Bernstein Raises PT on Intuitive Surgical, Inc. (ISRG) to $685; Maintains ‘Outperform’ Rating - Yahoo Finance
Baird Raises PT on Intuitive Surgical (ISRG) to $600 From $590, Keeps an Overweight Rating - msn.com
Intuitive Surgical Q2 2025 slides: 21% revenue growth fueled by da Vinci 5 adoption - Investing.com Nigeria
Intuitive Surgical Slides 1.09% on 97th-Ranked $900M Volume Amid Bearish Signals and Cautious Rally Outlook - AInvest
Intuitive Surgical Inc. Hits Oversold Level on RSI IndicatorInflation Watch & AI Powered Market Entry Strategies - beatles.ru
Surgical Robot Procedures Market | Industry Report, 2033 - Grand View Research
Intuitive Surgical Inc. Breakout Confirmed by Volume MetricsDividend Hike & Daily Growth Stock Tips - metal.it
ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue? - sharewise.com
Intuitive Surgical's $170 Billion Value Holds Room for Growth Despite Underperformance. - AInvest
Intuitive Surgical Has More Room To Grow (NASDAQ:ISRG) - Seeking Alpha
ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story - Nasdaq
Comparison of Surgical Outcomes Between the hinotori™ and da Vinci® Robotic Systems in Robot-Assisted Sacrocolpopexy: A Retrospective Study - Cureus
Surgical Robotics Simulation Market Industry Developments and Strategic Collaborations Accelerate Growth Trajectory - openPR.com
Intuitive Surgical’s ISRG Climbs 0.38% on $670M Volume, Ranked 142nd as Robotic Surgery Market Expands - AInvest
Global Clinical Robotic Systems Market Is Booming So Rapidly By 2032 | Intuitive Surgical Inc., Stryker Corporation - openPR.com
Here's Why We Think Intuitive Surgical (NASDAQ:ISRG) Might Deserve Your Attention Today - 富途牛牛
AI-based Surgical Robots Market Exclusive Report with Detailed - openPR.com
Apreo raises $130M for pivotal trial of emphysema device - MedTech Dive
Bay Area company breathes new life into fight against emphysema - The Business Journals
2 Surefire Stocks to Invest $1,000 in for the Long Haul - The Globe and Mail
Jim Cramer Praises Intuitive Surgical: "I Like That Company So Much" - AInvest
Jim Cramer on Intuitive Surgical: "I Like That Company So Much" - Yahoo Finance
FTC Maintains Support For Right-To-Repair In Med Robot Case - Law360
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock - MSN
Orthopedic Medical Robots Market Gains Momentum & Attracts - openPR.com
Intuitive Surgical Shares Dip 0.9% as Volume Plummets 20% to Rank 126th Despite Analyst Upgrades - AInvest
Intuitive Surgical, Inc. shares fall 1.82% intraday as Nasdaq gains led by Apple. - AInvest
Leerink Partners Raises PT on Intuitive Surgical, Maintains Buy Rating - AInvest
Leerink Partners Raised the Firm’s PT on Intuitive Surgical (ISRG), Kept a Buy Rating - Insider Monkey
Q2 Earnings Highs And Lows: Intuitive Surgical (NASDAQ:ISRG) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - ca.finance.yahoo.com
Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots - AOL.com
11 Best Stocks to Invest in for High Returns - Insider Monkey
Radiology Oncology Surgical Robots Market Generated - openPR.com
Fund Update: TRILLIUM ASSET MANAGEMENT, LLC added 23,043 shares of INTUITIVE SURGICAL ($ISRG) to their portfolio - Quiver Quantitative
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Intuitive Surgical Inc-Aktie (ISRG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GUTHART GARY S | Executive Chair of the Board o |
Jul 28 '25 |
Sale |
498.64 |
7,893 |
3,935,756 |
13,187 |
| GUTHART GARY S | Executive Chair of the Board o |
Jul 28 '25 |
Sale |
495.24 |
2,800 |
1,386,663 |
18,520 |
0.42%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):